Lexeo Therapeutics Inc. C...
5.46
-0.34 (-5.86%)
At close: Jan 15, 2025, 3:59 PM
5.49
0.55%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20
Net Income -66.39M -59.28M -50.62M -5.15M
Depreciation & Amortization 1.84M 1.15M 13.00K n/a
Stock-Based Compensation 3.04M 1.78M 386.00K n/a
Other Working Capital 1.66M 2.22M 3.03M 105.83K
Other Non-Cash Items 530.00K 4.50M -2.60M 1.87M
Deferred Income Tax n/a n/a n/a n/a
Change in Working Capital 1.48M 1.79M 6.04M 150.15K
Operating Cash Flow -59.50M -54.56M -44.18M -3.13M
Capital Expenditures -165.00K -901.00K -188.00K n/a
Acquisitions n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a
Other Investing Acitivies -50.00K n/a n/a n/a
Investing Cash Flow -165.00K -901.00K -188.00K n/a
Debt Repayment 3.58M -163.00K n/a 2.60M
Common Stock Repurchased n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a
Other Financial Acitivies -35.00K 352.00K 150.86M 29.78M
Financial Cash Flow 103.79M 189.00K 150.86M 32.38M
Net Cash Flow 44.13M -55.27M 106.49M 29.25M
Free Cash Flow -59.66M -55.46M -44.37M -3.13M